Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Osteopontin induces growth of metastatic tumors in a preclinical model of non-small lung cancer ; volume:31 ; number:1 ; day:23 ; month:3 ; year:2012 ; pages:1-12 ; date:12.2012
Journal of experimental & clinical cancer research ; 31, Heft 1 (23.3.2012), 1-12, 12.2012
- Urheber
-
Shojaei, Farbod
Scott, Nathan
Kang, Xiaolin
Lappin, Patrick B.
Fitzgerald, Amanda A.
Karlicek, Shannon
Simmons, Brett H.
Wu, Aidong
Lee, Joseph H.
Bergqvist, Simon
Kraynov, Eugenia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1756-9966-31-26
- URN
-
urn:nbn:de:101:1-2019080100032807720167
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shojaei, Farbod
- Scott, Nathan
- Kang, Xiaolin
- Lappin, Patrick B.
- Fitzgerald, Amanda A.
- Karlicek, Shannon
- Simmons, Brett H.
- Wu, Aidong
- Lee, Joseph H.
- Bergqvist, Simon
- Kraynov, Eugenia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Osteopontin is a prognostic biomarker in non-small cell lung cancer
Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer
Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
Management of Metastatic Nonsmall Cell Lung Cancer in Elderly
Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells
Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer
The effect of osteopontin and osteopontin-derived peptides on preterm brain injury
NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy
JNK signaling in breast cancer cells induces osteopontin and tenascin-C that promote therapy-resistant metastasis
White matter injury but not germinal matrix hemorrhage induces elevated osteopontin expression in human preterm brains
Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells
Osteopontin, osteoprotegerin and musculoskeletal ultrasound findings in first-degree relatives of rheumatoid arthritis: potential markers of preclinical disease
Osteopontin is a prognostic biomarker in non-small cell lung cancer
Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer
Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
Management of Metastatic Nonsmall Cell Lung Cancer in Elderly
Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells
Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer
The effect of osteopontin and osteopontin-derived peptides on preterm brain injury
NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy
JNK signaling in breast cancer cells induces osteopontin and tenascin-C that promote therapy-resistant metastasis
White matter injury but not germinal matrix hemorrhage induces elevated osteopontin expression in human preterm brains
Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells
Osteopontin, osteoprotegerin and musculoskeletal ultrasound findings in first-degree relatives of rheumatoid arthritis: potential markers of preclinical disease
Osteopontin is a prognostic biomarker in non-small cell lung cancer
Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer
Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells
Management of Metastatic Nonsmall Cell Lung Cancer in Elderly
Expression of osteopontin-5 splice variant in the mouse primary and metastatic breast cancer cells
Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer
The effect of osteopontin and osteopontin-derived peptides on preterm brain injury
NHS-IL2 combined with radiotherapy: preclinical rationale and phase Ib trial results in metastatic non-small cell lung cancer following first-line chemotherapy
JNK signaling in breast cancer cells induces osteopontin and tenascin-C that promote therapy-resistant metastasis
White matter injury but not germinal matrix hemorrhage induces elevated osteopontin expression in human preterm brains
Enhanced osteopontin splicing regulated by RUNX2 is HDAC-dependent and induces invasive phenotypes in NSCLC cells